197 related articles for article (PubMed ID: 21756359)
1. Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry.
Tschöpe D; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Gitt AK
Cardiovasc Diabetol; 2011 Jul; 10():66. PubMed ID: 21756359
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry.
Gitt AK; Bramlage P; Binz C; Krekler M; Deeg E; Tschöpe D
Herz; 2012 May; 37(3):294-300. PubMed ID: 22476616
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
Gitt AK; Bramlage P; Binz C; Krekler M; Plate T; Deeg E; Tschöpe D;
Eur J Prev Cardiol; 2012 Aug; 19(4):765-72. PubMed ID: 21628353
[TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry.
Gitt AK; Bramlage P; Binz C; Krekler M; Deeg E; Tschöpe D
Int J Clin Pract; 2013 Oct; 67(10):1005-14. PubMed ID: 23981060
[TBL] [Abstract][Full Text] [Related]
5. Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus.
Tschöpe D; Bramlage P; Schneider S; Gitt AK
Diab Vasc Dis Res; 2016 Jan; 13(1):2-12. PubMed ID: 26567123
[TBL] [Abstract][Full Text] [Related]
6. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.
Bramlage P; Binz C; Gitt AK; Krekler M; Plate T; Deeg E; Tschöpe D
Cardiovasc Diabetol; 2010 Sep; 9():53. PubMed ID: 20843379
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.
Bramlage P; Gitt AK; Schneider S; Deeg E; Tschöpe D;
BMC Cardiovasc Disord; 2014 Nov; 14():162. PubMed ID: 25410473
[TBL] [Abstract][Full Text] [Related]
8. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia.
Bramlage P; Gitt AK; Binz C; Krekler M; Deeg E; Tschöpe D
Cardiovasc Diabetol; 2012 Oct; 11():122. PubMed ID: 23039216
[TBL] [Abstract][Full Text] [Related]
10. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.
Liu SC; Tu YK; Chien MN; Chien KL
Diabetes Obes Metab; 2012 Sep; 14(9):810-20. PubMed ID: 22486990
[TBL] [Abstract][Full Text] [Related]
11. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
12. Changes in incidence of severe hypoglycaemia in people with type 2 diabetes from 2006 to 2016: analysis based on health insurance data in Germany considering the anti-hyperglycaemic medication.
Müller N; Lehmann T; Klöss A; Günster C; Kloos C; Müller UA
Diabet Med; 2020 Aug; 37(8):1326-1332. PubMed ID: 32145093
[TBL] [Abstract][Full Text] [Related]
13. Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes.
Ou HT; Chang KC; Li CY; Wu JS
Br J Clin Pharmacol; 2017 Jul; 83(7):1556-1570. PubMed ID: 28109184
[TBL] [Abstract][Full Text] [Related]
14. Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.
Rathmann W; Kostev K; Gruenberger JB; Dworak M; Bader G; Giani G
Diabetes Obes Metab; 2013 Jan; 15(1):55-61. PubMed ID: 22862879
[TBL] [Abstract][Full Text] [Related]
15. Composite efficacy parameters and predictors of hypoglycaemia in basal-plus insulin therapy--a combined analysis of 713 type 2 diabetic patients.
Seufert J; Brath H; Pscherer S; Borck A; Bramlage P; Siegmund T
Diabetes Obes Metab; 2014 Mar; 16(3):248-54. PubMed ID: 24033863
[TBL] [Abstract][Full Text] [Related]
16. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Kostev K; Dippel FW; Rathmann W
Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of vildagliptin as a second-line therapy vs other oral antidiabetic agents in patients with type 2 diabetes: Czech results within the worldwide prospective cohort EDGE study].
Haluzík M; Veselá V; Gerle J; Brada M; Dohnalová L; Edelsberger T; Houdová J
Vnitr Lek; 2013 Dec; 59(12):1049-56. PubMed ID: 24350936
[TBL] [Abstract][Full Text] [Related]
18. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
Diabetes Obes Metab; 2016 Sep; 18(9):907-15. PubMed ID: 27161418
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
